Bayer's Roundup survives U.S. regulatory battles—despite lawsuits and state bans
Bayer's future in the U.S. herbicide market has been a topic of high-level discussions for years. The company's CEO met with White House officials to address concerns over Roundup
As early as the Trump administration, Bayer warned it might withdraw Roundup from the U.S. market. Regulatory uncertainty and the threat of a federal ban drove these concerns. The company also signalled it could handle billions in litigation costs tied to health claims against the herbicide.
Despite ongoing lawsuits and some state-level restrictions—like California's warning labels—Roundup's dominance has held firm. Since the 2020 *Make America Healthy Again* report, glyphosate herbicides have maintained an 80-90% share of the U.S. market, according to USDA and industry data through 2025. The White House took note of the broader implications. A potential ban on Roundup could disrupt phosphorus supplies, a mineral vital for agriculture, defence manufacturing, and semiconductor production. These concerns kept federal restrictions off the table, even as legal and regulatory pressures persisted.
Bayer's warnings and high-level talks have so far kept Roundup widely available in the U.S. The herbicide's market position remains strong, and no federal ban has materialised. For now, the product's role in key industries—and the economic risks of losing it—continue to shape policy decisions.
